Selling Sickness offers a rigorous investigation into how major pharmaceutical companies reshape the definitions of illness to expand markets. Ray Moynihan and Allan Cassels reveal strategies that rebrand ordinary life experiences—like nasal congestion, mood fluctuations, or childhood activity—as medical conditions demanding drug-based solutions.

This analysis shows how lowering thresholds for diagnosis and broadening disease categories generate millions of new patients and fuel soaring profits, posing financial risks to national healthcare systems. The Canadian edition adds context on regulatory practices, market influences, and why Canadians should be alert to these trends.

Key insights

• Mechanisms of “disease mongering” and marketing tactics
• Economic pressures on healthcare budgets and policy
• Impact on patient care, medical research, and public trust

Combining investigative reporting with clear examples, this book equips readers with the knowledge to question medical claims, understand the role of big pharma, and advocate for responsible healthcare practices.

We ship at a flat rate of $9.99 per order. Orders $45 and up ship free of charge.